Literature DB >> 17785947

Arsenic accumulation decreased in metallothionein null Cisplatin-resistant cell lines.

Toshihiro Suzuki1, Shigeki Ohata, Tadayasu Togawa, Seiichiro Himeno, Shinzo Tanabe.   

Abstract

Metallothionein (MT) is known to play an important role in the resistance of tumor cells to cis-diamminedichloroplatinum (II) (cisplatin). To identify non-MT factors of cisplatin resistance, we characterized cisplatin-resistant cell lines derived from MT-null cells. All of the cisplatin-resistant MT- null cell lines, namely MKCr-1, -3, -4, -12, and -13, showed strong cisplatin resistance and decreased platinum accumulation. Some multidrug resistance proteins (MRPs) have been reported to contribute to cisplatin resistance. However, no significant difference of the MRPs was observed in any of these cell lines. The MKCrs showed cross-resistance to other metals such as arsenite, arsenate, cadmium and antimony. The arsenate and arsenite sensitivities were highly correlated with sensitivity to cisplatin. In addition, the degree of arsenite accumulation was correlated with the degree of cisplatin accumulation. These results suggest that the cisplatin resistance was strongly correlated with the arsenite transport mechanism in these cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785947     DOI: 10.2131/jts.32.321

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  3 in total

1.  Utilization of arsenic trioxide as a treatment of cisplatin-resistant non-small cell lung cancer PC-9/CDDP and PC-14/CDDP cells.

Authors:  Toshihiro Suzuki; Kenichi Ishibashi; Atsushi Yumoto; Kazuto Nishio; Yuki Ogasawara
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

2.  Cellular responses to Cisplatin-induced DNA damage.

Authors:  Alakananda Basu; Soumya Krishnamurthy
Journal:  J Nucleic Acids       Date:  2010-08-08

Review 3.  Arsenic binding to proteins.

Authors:  Shengwen Shen; Xing-Fang Li; William R Cullen; Michael Weinfeld; X Chris Le
Journal:  Chem Rev       Date:  2013-06-28       Impact factor: 60.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.